Want to see SSII full AI Analyst Report?
SSII Stock Chart & Stats
$6.42
$0.01(0.13%)
At close: 4:00 PM EST
$6.42
$0.01(0.13%)
Day’s Range― - ―
52-Week Range$3.11 - $10.00
Previous CloseN/A
Volume157.00
Average Volume (3M)65.78K
Market Cap
$720.47M
Enterprise Value$645.12M
Total Cash (Recent Filing)$15.98M
Total Debt (Recent Filing)$13.82M
Price to Earnings (P/E)―
Beta9.29
Next Earnings
Aug 06, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding200,131,530
10 Day Avg. Volume66,346
30 Day Avg. Volume65,782
Financial Highlights & Ratios
PEG Ratio2.12
Price to Book (P/B)28.24
Price to Sales (P/S)25.40
P/FCF Ratio-48.61
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue13.32
Enterprise Value/Gross Profit27.52
Enterprise Value/Ebitda-174.01
Forecast
1Y Price Target
$7.00Price Target Upside9.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Margin ExpansionSustained top-line growth alongside a near-5ppt gross margin improvement indicates improving unit economics and operating leverage. These trends support durable gross-profit generation as system placements scale, helping the business move toward structural profitability over coming quarters.
Installed Base And Clinical AdoptionA growing installed base across multiple geographies drives recurring consumables, service and training revenue. Broad multi-specialty procedural use and thousands of completed surgeries create a structural runway for repeat instrument sales and service contracts, underpinning durable recurring revenue.
Conservative LeverageVery low leverage gives the company financial flexibility while scaling commercial operations and pursuing regulatory entries. Limited interest burden preserves cash flow capacity and reduces bankruptcy risk, enabling continued investment in adoption and product development.
Bears Say
Negative Operating And Free Cash FlowPersistently negative operating and free cash flow increase reliance on external financing and constrain the firm’s ability to self-fund commercial expansion. Until cash generation turns positive, capital raises or tighter spending will be required, limiting strategic optionality.
Ongoing Net LossesMaterial negative net margins mean returns on equity remain negative and profitability is not yet established. Continued losses can impair ROE, strain investor confidence, and lengthen the timeline before the business can sustainably reinvest operating profits to fund growth.
Equity Financing / Potential DilutionAn at-the-market equity program provides near-term funding flexibility but signals ongoing capital needs. Repeated use can dilute existing shareholders and indicates internal cash flow is insufficient to cover growth, potentially pressuring per-share metrics and capital allocation choices.
SSII FAQ
What was Ss Innovations International, Inc’s price range in the past 12 months?
Ss Innovations International, Inc lowest stock price was $3.11 and its highest was $10.00 in the past 12 months.
What is Ss Innovations International, Inc’s market cap?
Ss Innovations International, Inc’s market cap is $720.47M.
When is Ss Innovations International, Inc’s upcoming earnings report date?
Ss Innovations International, Inc’s upcoming earnings report date is Aug 06, 2026 which is in 27 days.
How were Ss Innovations International, Inc’s earnings last quarter?
Ss Innovations International, Inc released its earnings results on May 13, 2026. The company reported -$0.02 earnings per share for the quarter, the consensus estimate of -$0.02 by $0.
Is Ss Innovations International, Inc overvalued?
According to Wall Street analysts Ss Innovations International, Inc’s price is currently Undervalued.
Does Ss Innovations International, Inc pay dividends?
Ss Innovations International, Inc does not currently pay dividends.
What is Ss Innovations International, Inc’s EPS estimate?
Ss Innovations International, Inc’s EPS estimate is -0.01.
How many shares outstanding does Ss Innovations International, Inc have?
Ss Innovations International, Inc has 200,131,530 shares outstanding.
What happened to Ss Innovations International, Inc’s price movement after its last earnings report?
Ss Innovations International, Inc reported an EPS of -$0.02 in its last earnings report, expectations of -$0.02. Following the earnings report the stock price went down -2.92%.
Which hedge fund is a major shareholder of Ss Innovations International, Inc?
Currently, no hedge funds are holding shares in SSII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SS Innovations International Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (9.03% Upside)
$7.00 (9.03% Upside)
Blogger Sentiment
Bullish
SSII Sentiment 70%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.08%
12-Months-Change
Fundamentals
Return on Equity
-23.00%
Trailing 12-Months
Asset Growth
42.69%
Trailing 12-Months
Company Description
Ss Innovations International, Inc
SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite of surgical instruments designed to facilitate various operations, including robotic cardiac surgery. The company also provides SSI Maya, a dedicated platform for robotic surgical interventions, along with OMNI 3D HD, which delivers a real-time, high-definition 3D perspective of the surgical field within the operating room.
SSII Stock 12 Month Forecast
Average Price Target
$7.00
▲(9.03% Upside)
Technical Analysis
Conmed
―
Artivion
―
Integra Lifesciences
―
Tandem Diabetes Care
―
Establishment Labs Holdings
―
Ownership Overview
67.67% Insiders
0.46% Mutual Funds
<0.01% Other Institutional Investors
31.76% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---













